Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-102326

Director sold 134,261 shares at an average $45.03 ($6,045,783)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kersten Dirk Director 2024-08-28 Sale 10b5-1 −16,386 $44.41 $727,702 549,175 I
Kersten Dirk Director 2024-08-28 Sale 10b5-1 −61,467 $44.94 $2,762,327 487,708 I
Kersten Dirk Director 2024-08-29 Sale 10b5-1 −45,640 $45.19 $2,062,472 442,068 I
Kersten Dirk Director 2024-08-29 Sale 10b5-1 −10,768 $45.81 $493,282 431,300 I
Open-market sales · 134,261 sh · avg $45.03 · $6,045,783
Loading xslF345X05/ownership.xml…